| | Evaluation of Chemical Warfare Agent Percutaneous Vapor |
| | 0,29 | | MB | Toxicity: Derivation of Toxicity Guidelines for Assessing |
| | 42 | | stron | Chemical Protective Ensembles |
| | 3805 | | ID | Oak Ridge National Laboratory |
| | 2003 | | rok |
| | CONTENTS |
| | List of Tables .. v |
| | Acronyms .. vii |
| | Acknowledgments . ix |
| | Executive summary .. xi |
| | Abstract xiii |
| | 1. INTRODUCTION. 1 |
| | 2. STATEMENT OF PURPOSE . 2 |
| | 3. BACKGROUND 3 |
| | 3.1 EVALUATIONS OF CHEMICAL WARFARE AGENT PROTECTIVE CLOTHING.. 3 |
| | 3.2 RECOMMENDATIONS OF THE MAN-IN-SIMULANT (MIST) REPORT (NRC/BAST 1997) 3 |
| | 3.2.1 General Test Protocols .. 4 |
| | 3.2.2 Use of Biomarkers 4 |
| | 3.2.3 Use of Methyl Salicylate (MeS) as a Simulant for CPE Testing . 4 |
| | 4. SUMMARY OF LITERATURE FINDINGS.. 5 |
| | 4.1 EFFECTS OF DERMAL EXPOSURES 5 |
| | 4.1.1 Nerve Agents.. 5 |
| | 4.1.2 Vesicant Agents. 5 |
| | 4.2 ASSESSMENT OF REGIONAL SKIN VARIATION IN ABSORPTION; SUSCEPTIBILITY BY |
| | ANATOMIC SITE 6 |
| | 4.2.1 Nerve Agents.. 7 |
| | 4.2.2 Vesicant Agents. 8 |
| | 4.2.3 Body Region Variation in Susceptibility.. 9 |
| | 4.3 EXISTING TOXICITY CRITERIA 11 |
| | 4.3.1 Acute Human Toxicity Estimates (NRC/COT 1997). 11 |
| | 4.3.2 Current Military Estimates (Grotte and Yang 2001).. 11 |
| | 5. EVALUTION AND DISCUSSION.. 13 |
| | 5.1 DETERMINING TOXICITY GUIDELINE CRITERIA FOR CIVILIAN CPE.. 13 |
| | 5.2 METHODS EVALUATED TO ESTIMATE MINIMAL EFFECT LEVELS .. 13 |
| | 5.2.1 Method A.. 13 |
| | 5.2.2 Method B.. 14 |
| | 5.2.3 Method C.. 14 |
| | 5.2.4 Method D.. 15 |
| | 5.3 SUMMARY OF METHODS EVALUATION.. 17 |
| | 5.4 EXPOSURE DURATION. 17 |
| | 6. CONCLUSIONS 18 |
| | 7. RECOMMENDATIONS .. 20 |
| | 8. REFERENCES 21 |